Influence of Conbercept on diabetic retinopathy patients with macular edema
YIN Xiaomin1 XUE Han2 ZHAI Liping3
1.Department of Ophthalmology, Taizhou Hospital of Traditional Chinese Medicine, Jiangsu Province, Taizhou 225300, China;
2.Department of Critical Care Medicine, Taizhou People’s Hospital, Jiangsu Province, Taizhou 225300, China;
3.Department of Endocrinology, Taizhou Hospital of Traditional Chinese Medicine, Jiangsu Province, Taizhou 225300, China
Abstract:Objective To investigate the influence of Conbercept on diabetic retinopathy patients with macular edema. Methods A total of 84 diabetic retinopathy patients (84 eyes in total) with macular edema admitted to Taizhou Hospital of Traditional Chinese Medicine of Jiangsu Province from January 2016 to May 2021 were selected as the research objects. They were divided into control group and study group by random number table method, with 42 cases in each group. The control group was treated with retinal photocoagulation, and the study group was treated with Conbercept on the basis of the control group. The course of treatment in both groups was three months. The macular foveal central macular thickness (CMT), best corrected visual acuity (BCVA), erythroeyte deformation index (EDI), plasma viscosity (PV), and mean defect of visual field (MD) were compared between the two groups before and after treatment. The macular improvement and complications of the two groups were recorded. Results After three months of treatment, the CMT, EDI, PV, and MD of the two groups were lower than those before treatment, and the BCVA was higher than that before treatment, the CMT, EDI, and PV of the study group were lower than those of the control group, and the BCVA was higher than that of the control group (P < 0.05). The macular regression grade of the study group was better than that of the control group (P < 0.05). There was no significant difference in the total incidence of complications between the two groups (P > 0.05). Conclusion Conbercept combines with retinal photocoagulation can improve visual acuity, improve microcirculation, reduce macular edema, and improve visual field loss in diabetic retinopathy patients with macular edema, which is safe and reliable.